# Medicinall

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medicinall

- Industry: Healthcare
- Headquarters: UK
- Website: www.medall.org
- Total disclosed funding: $3.9M
- Latest round: Seed (Oct 6, 2021)
- Investors on record: 5

## About

Based in County Antrim, UK, and founded in 2017 by its CEO, Dr. Phil McElnay, Medicinall Limited, trading as MedAll, operates as a medtech platform that helps healthcare organisations build a culture of learning and grow the community. In January 2022, Medicinall Limited raised USD 3.4 million in seed funding led by Connect Ventures, with participation from Nina Capital. As of 2022, the company's platform has served more than 900 healthcare organisations in more than 20 countries. 

Medicinall Limited offers a live video streaming platform and enables healthcare organisations to build and implement digital training and certifications without having to delve into any complicated coding, as well as host live and hybrid events, including courses, conferences, workshops, webinars, and sessions. The company's client base includes BAPS, UCL Surgical Society, ASME, University College Dublin Surgical Society, and ASiT.

Medicinall Limited will use the seed funding to develop its training platform for healthcare workers and expand its global reach.

## Funding rounds

- Seed, Oct 6, 2021, $3.9M — Ascension Ventures, Seedcamp, Connect Ventures, Techstart Ventures, Nina Capital

## Investors

- Ascension Ventures (https://capitalatlas.ai/funds/ascension-ventures) — Seed
- Seedcamp (https://capitalatlas.ai/funds/seedcamp) — Seed
- Connect Ventures — Seed
- Techstart Ventures (https://capitalatlas.ai/funds/techstart-ventures) — Seed
- Nina Capital (https://capitalatlas.ai/funds/nina-capital) — Seed